Sientra (NASDAQ:SIEN) Now Covered by Analysts at started coverage on shares of Sientra (NASDAQ:SIENFree Report) in a research note published on Wednesday. The firm issued a hold rating on the medical instruments supplier’s stock.

Separately, Craig Hallum reiterated a hold rating on shares of Sientra in a report on Tuesday, October 31st.

Check Out Our Latest Report on SIEN

Sientra Trading Up 2.7 %

Sientra stock opened at $0.60 on Wednesday. The stock has a 50-day simple moving average of $0.64 and a 200 day simple moving average of $1.62. Sientra has a 52 week low of $0.56 and a 52 week high of $4.94.

Sientra (NASDAQ:SIENGet Free Report) last posted its earnings results on Thursday, November 9th. The medical instruments supplier reported ($1.03) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.48) by ($0.55). The company had revenue of $19.54 million during the quarter, compared to analyst estimates of $19.45 million. On average, sell-side analysts anticipate that Sientra will post -3.66 earnings per share for the current year.

Hedge Funds Weigh In On Sientra

A number of large investors have recently made changes to their positions in SIEN. Millennium Management LLC grew its holdings in Sientra by 253.4% in the 2nd quarter. Millennium Management LLC now owns 1,989,323 shares of the medical instruments supplier’s stock valued at $1,666,000 after buying an additional 1,426,343 shares in the last quarter. Renaissance Technologies LLC grew its stake in shares of Sientra by 758.0% in the fourth quarter. Renaissance Technologies LLC now owns 966,100 shares of the medical instruments supplier’s stock valued at $196,000 after acquiring an additional 853,500 shares in the last quarter. Vanguard Group Inc. increased its position in Sientra by 13.3% during the first quarter. Vanguard Group Inc. now owns 3,106,395 shares of the medical instruments supplier’s stock worth $6,896,000 after acquiring an additional 364,180 shares during the period. Wells Fargo & Company MN raised its stake in Sientra by 229,051.4% in the 2nd quarter. Wells Fargo & Company MN now owns 316,229 shares of the medical instruments supplier’s stock worth $927,000 after purchasing an additional 316,091 shares in the last quarter. Finally, RTW Investments LP bought a new stake in Sientra in the 3rd quarter valued at about $845,000. Institutional investors own 15.38% of the company’s stock.

About Sientra

(Get Free Report)

Sientra, Inc, a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names.

Featured Stories

Receive News & Ratings for Sientra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra and related companies with's FREE daily email newsletter.